---
figid: PMC5941661__10.1177_1753466618767611-fig1
figlink: /pmc/articles/PMC5941661/figure/fig1-1753466618767611/
number: Figure 1
caption: 'Mechanism of action of dabrafenib and trametinib: binding of BRAF and MEK
  inhibitors generates a blockade point in MAPK pathway at two different levels, inhibiting
  oncogenic downstream signaling and causing cell cycle arrest.MAPK: mitogen-activated
  protein kinase.'
pmcid: PMC5941661
papertitle: 'Dabrafenib in combination with trametinib in the treatment of patients
  with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical
  evidence and experience.'
reftext: Arjun Khunger, et al. Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618767611.
pmc_ranked_result_index: '3796'
pathway_score: 0.9690469
filename: 10.1177_1753466618767611-fig1.jpg
figtitle: Dabrafenib and trametinib acting on the MAPK pathway
year: '2018'
organisms: Homo sapiens
ndex: 4e1e5ea9-dec8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5941661__10.1177_1753466618767611-fig1.html
  '@type': Dataset
  description: 'Mechanism of action of dabrafenib and trametinib: binding of BRAF
    and MEK inhibitors generates a blockade point in MAPK pathway at two different
    levels, inhibiting oncogenic downstream signaling and causing cell cycle arrest.MAPK:
    mitogen-activated protein kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NRAS
  - BRAF
  - MAP2K1
  - ARAF
  - HRAS
  - MAPK3
  - RAF1
  - KRAS
  - MAPK1
  - MAP2K2
  - RAF EDabrafenib
  - Trametinib
  - ESCH772984
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK1/2-Trametinib
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
chemicals:
- word: RAF EDabrafenib
  source: MESH
  identifier: C559019
- word: Trametinib
  source: MESH
  identifier: C560077
- word: ESCH772984
  source: MESH
  identifier: C587178
diseases: []
---
